Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

2 marketed · 6 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

What are Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.'s marketed drugs?

Top marketed products include Hypromellose Eye Drop, Hypromellose Eye Drops.

What is Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.'s pipeline?

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. has 6 drugs in Phase 3, 2 in Phase 2, 0 in Phase 1. Late-stage candidates include Betaxolol eye drops, CsA Ophthalmic Gel, CsA-PG Ophthalmic Gel, Cyclosporine ophthalmic gel vehicle.

Related